101 related articles for article (PubMed ID: 30481525)
1. A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells.
Majmudar H; Hao M; Sankaranarayanan NV; Zanotti B; Volin MV; Desai UR; Tiwari V
Antiviral Res; 2019 Jan; 161():154-162. PubMed ID: 30481525
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule.
Elste J; Kaltenbach D; Patel VR; Nguyen MT; Sharthiya H; Tandon R; Mehta SK; Volin MV; Fornaro M; Tiwari V; Desai UR
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121406
[TBL] [Abstract][Full Text] [Related]
3. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R
mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of human iris stromal cells to herpes simplex virus 1 entry.
Baldwin J; Park PJ; Zanotti B; Maus E; Volin MV; Shukla D; Tiwari V
J Virol; 2013 Apr; 87(7):4091-6. PubMed ID: 23345512
[TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.
Al-Horani RA; Gailani D; Desai UR
Thromb Res; 2015 Aug; 136(2):379-87. PubMed ID: 25935648
[TBL] [Abstract][Full Text] [Related]
6. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.
Lin LT; Chen TY; Chung CY; Noyce RS; Grindley TB; McCormick C; Lin TC; Wang GH; Lin CC; Richardson CD
J Virol; 2011 May; 85(9):4386-98. PubMed ID: 21307190
[TBL] [Abstract][Full Text] [Related]
7. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.
Hubbard S; Choudhary S; Maus E; Shukla D; Swenson S; Markland FS; Tiwari V
Antivir Ther; 2012; 17(7):1319-26. PubMed ID: 22875654
[TBL] [Abstract][Full Text] [Related]
8. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.
Al-Horani RA; Desai UR
J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380
[TBL] [Abstract][Full Text] [Related]
9. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effects of Cacicol
Deback C; Rousseau A; Breckler M; Molet L; Boutolleau D; Burrel S; Roque-Afonso AM; Labetoulle M
Antivir Ther; 2018; 23(8):665-675. PubMed ID: 30028308
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
[TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
Rogalin HB; Heldwein EE
J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677
[TBL] [Abstract][Full Text] [Related]
15. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
[TBL] [Abstract][Full Text] [Related]
17. HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection.
Sharthiya H; Seng C; Van Kuppevelt TH; Tiwari V; Fornaro M
J Neurovirol; 2017 Jun; 23(3):483-491. PubMed ID: 28326469
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.
Antoine TE; Shukla D
Antivir Ther; 2014; 19(1):15-29. PubMed ID: 23813409
[TBL] [Abstract][Full Text] [Related]
19. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.
Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A
J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
